NO20003221L - Ny G-proteinkoblet reseptor - Google Patents

Ny G-proteinkoblet reseptor

Info

Publication number
NO20003221L
NO20003221L NO20003221A NO20003221A NO20003221L NO 20003221 L NO20003221 L NO 20003221L NO 20003221 A NO20003221 A NO 20003221A NO 20003221 A NO20003221 A NO 20003221A NO 20003221 L NO20003221 L NO 20003221L
Authority
NO
Norway
Prior art keywords
protein
new
coupled receptor
directed
present
Prior art date
Application number
NO20003221A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003221D0 (no
Inventor
Sultan Ahmad
Denis Banville
Yves Fortin
Paola Lembo
Dajan O'donell
Shi-Hsiang Shen
Original Assignee
Astrazeneca Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Canada Inc filed Critical Astrazeneca Canada Inc
Publication of NO20003221D0 publication Critical patent/NO20003221D0/no
Publication of NO20003221L publication Critical patent/NO20003221L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20003221A 1997-12-22 2000-06-21 Ny G-proteinkoblet reseptor NO20003221L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704836A SE9704836D0 (sv) 1997-12-22 1997-12-22 Novel receptor
PCT/SE1998/002348 WO1999032519A1 (en) 1997-12-22 1998-12-16 Novel g protein-coupled receptor

Publications (2)

Publication Number Publication Date
NO20003221D0 NO20003221D0 (no) 2000-06-21
NO20003221L true NO20003221L (no) 2000-08-10

Family

ID=20409539

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003221A NO20003221L (no) 1997-12-22 2000-06-21 Ny G-proteinkoblet reseptor

Country Status (19)

Country Link
US (3) US6696257B1 (de)
EP (1) EP1051434B1 (de)
JP (1) JP2001526064A (de)
KR (1) KR20010033486A (de)
CN (1) CN1284966A (de)
AT (1) ATE325132T1 (de)
AU (1) AU756861B2 (de)
BR (1) BR9814335A (de)
CA (1) CA2316280C (de)
DE (1) DE69834432T2 (de)
ES (1) ES2262252T3 (de)
IL (1) IL136728A0 (de)
IS (1) IS5543A (de)
NO (1) NO20003221L (de)
PL (1) PL341524A1 (de)
SE (1) SE9704836D0 (de)
SK (1) SK8752000A3 (de)
TR (1) TR200001861T2 (de)
WO (1) WO1999032519A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
CA2344459A1 (en) * 1998-10-01 2000-04-13 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
CA2357807A1 (en) * 1999-01-04 2000-07-13 Lexicon Genetics Incorporated Human seven-transmembrane receptors
EP1242448A2 (de) * 1999-11-17 2002-09-25 Arena Pharmaceuticals, Inc. Endogene und nicht -endogene, konstitutiv aktivierte, menschliche, mit g-proteinen gekoppelten rezeptoren
AU5787501A (en) * 1999-12-28 2001-07-09 Pharmacia & Upjohn Company Novel G protein-coupled receptors
EP1268795A2 (de) * 2000-03-24 2003-01-02 Bayer Aktiengesellschaft Regulation des humanen mas-oncogenischen g-protein-gekoppelten rezeptors
WO2001072840A2 (en) * 2000-03-27 2001-10-04 Pe Corporation (Ny) Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
AU2001247766A1 (en) * 2000-03-29 2001-10-08 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
GB0008252D0 (en) * 2000-04-04 2000-05-24 Janssen Pharmaceutica Nv G protien coupled receptor
EP1303601A2 (de) * 2000-04-06 2003-04-23 PHARMACIA & UPJOHN COMPANY G-protein-gekoppelte rezeptoren
EP1280823A2 (de) * 2000-04-24 2003-02-05 PE Corporation (NY) Isolierte menschliche g-proteingekoppelte rezeptoren aus der subfamilie der aminergen rezeptoren, dafür kodierende nukleinsäuresequenzen und ihre verwendungen
US7691604B1 (en) 2000-05-04 2010-04-06 California Institute Of Technology MRG polypeptides and nucleic acids encoding the same
WO2001083555A2 (en) * 2000-05-04 2001-11-08 California Institute Of Technology Pain signaling molecules
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7510845B2 (en) * 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
AU2001265717A1 (en) * 2000-06-20 2002-01-02 Euroscreen S.A. A recombinant cell line expressing gpcrx11 as a functional receptor validated byangiopeptin and useful for screening of agonists and antagonists
AU2001279117A1 (en) * 2000-08-02 2002-02-13 Pharmacia And Upjohn Company G protein-coupled receptors
IL144655A0 (en) * 2000-08-04 2002-05-23 Switch Biotech Ag Polypeptides or nucleic acids encoding of a family of g-protein coupled receptors and their use
AU2001296650A1 (en) * 2000-10-05 2002-04-15 Millennium Pharmaceuticals, Inc. Seven-transmembrane (7tm) receptors and uses thereof
CA2423596A1 (en) 2000-10-17 2002-04-25 Astrazeneca Ab Assays
US20040076951A1 (en) * 2000-10-25 2004-04-22 Ming-Hui Wei Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
CA2431655A1 (en) * 2000-11-15 2002-05-23 Akiko Itai Method of profiling protein
CA2430719A1 (en) 2000-12-22 2002-07-04 Astrazeneca Ab A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
WO2002062995A2 (en) * 2001-02-08 2002-08-15 Bayer Aktiengesellschaft Human dorsal root receptor-like g protein-coupled receptor
DK1399744T3 (da) 2001-06-27 2008-09-22 Janssen Pharmaceutica Nv EPF-receptorassays, forbindelser og terapeutiske præparater
EP1424557A4 (de) * 2001-09-03 2007-12-26 Takeda Pharmaceutical Verwendung eines g-protein-gekoppelten rezeptorproteins
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
ATE545866T1 (de) 2002-04-12 2012-03-15 Schering Corp Liganden von g-protein-gekoppelten rezeptoren und verfahren
US20040121410A1 (en) * 2002-12-20 2004-06-24 Anderson David J. Pain signaling molecules
WO2004111642A2 (en) * 2003-06-16 2004-12-23 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 1 (snsr1)
WO2005003780A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 4 (snsr4)
WO2005003779A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 3 (snsr3)
WO2005003762A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 2 (snsr2)
WO2005003763A2 (en) * 2003-06-18 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3)
EP2571989A4 (de) 2010-05-18 2014-08-13 Univ Mcgill Verfahren zur reduzierung der expression bösartiger gliome aus herunterregulierten nierenzellkarzinomen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508384A (en) 1992-09-10 1996-04-16 New York University Polypeptide derived from a popamine receptor, and compositions and methods thereof
US5556780A (en) * 1993-07-30 1996-09-17 The Board Of Trustees For The Leland Stanford Junior University CDNAS encoding mouse and rat type-2 angiotensin II receptors and their expression in host cells

Also Published As

Publication number Publication date
SE9704836D0 (sv) 1997-12-22
NO20003221D0 (no) 2000-06-21
TR200001861T2 (tr) 2000-11-21
WO1999032519A1 (en) 1999-07-01
AU1990499A (en) 1999-07-12
AU756861B2 (en) 2003-01-23
SK8752000A3 (en) 2001-01-18
BR9814335A (pt) 2000-10-10
US6696257B1 (en) 2004-02-24
WO1999032519A9 (en) 1999-09-30
IS5543A (is) 2000-06-21
EP1051434A1 (de) 2000-11-15
CA2316280C (en) 2010-07-13
US20090226932A1 (en) 2009-09-10
IL136728A0 (en) 2001-06-14
ES2262252T3 (es) 2006-11-16
DE69834432D1 (de) 2006-06-08
US20060068466A1 (en) 2006-03-30
JP2001526064A (ja) 2001-12-18
PL341524A1 (en) 2001-04-23
ATE325132T1 (de) 2006-06-15
DE69834432T2 (de) 2007-04-12
CN1284966A (zh) 2001-02-21
CA2316280A1 (en) 1999-07-01
EP1051434B1 (de) 2006-05-03
US7217693B2 (en) 2007-05-15
KR20010033486A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
NO20003221D0 (no) Ny G-proteinkoblet reseptor
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
HK1029595A1 (en) Cyclic antagonists of c5a receptors and g protein-coupled receptors
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
HUP0401542A2 (hu) Follisztatin alkalmazása izomtömeg növelésére
ATE387461T1 (de) Neuer g-protein-gekoppelter rezeptor
EA199901013A1 (ru) Гели пролонгированного действия
DE60332320D1 (de) Neues screening-verfahren
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
PT1083903E (pt) Indenopirrolocarbazoles em ponte
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
CO5460266A1 (es) Novedosos analogos de la somatostatina
SE9602822D0 (sv) New receptor
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
ATE424411T1 (de) Varianten von säugerprolactin
SE9804274D0 (sv) Novel receptor
EA200100037A1 (ru) Ангиостатин-связывающий белок
SE9902763D0 (sv) Novel receptor
SE9604439D0 (sv) New receptor
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
EA200000365A1 (ru) Полиморфные модификации дофетилида
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
DK1401871T3 (da) Immunologisk bindingsmolekyle, der hæmmer den syncytiale fusion af trophoblastceller
EA200100110A1 (ru) Нейротрофические факторы
TR200100219T2 (tr) IL-8 Reseptörü Antagonistleri

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application